The ethical dilemma which has caused many to oppose stem cell research may have been eliminated by a new breakthrough in the cutting-edge treatment which could be used to treat Parkinson's and Alzheimer's disease.
Discovered by scientists in Britain and Canada, the new development allows researchers around the world to use regular skin cells instead of human embryos, which has caused many campaigns and lobbying against the morals of science.
Sir Ian Wilmut, who was in charge of the team that cloned Dolly the Sheep and is currently the head of the MRC Centre for Regenerative Medicine (CRM), said the development was a step in the right direction.
He continued: "The team has made great progress and combining this work with that of other scientists working on stem cell differentiation, there is hope that the promise of regenerative medicine could soon be met."
CRM aims to bring together the technological evolution found in stem cell research with scientists and clinicians at the University of Edinburgh Medical School to push the boundaries of the facility and world knowledge of the subject.
Please click here for advice to help you find the right type of care.